Medicare Enrolled

Dr. Jennifer Ding

Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4383 MEDICAL DR, San Antonio, TX 78229
2105932584
In practice since 2014 (12 years)
NPI: 1457779027 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ding from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ding? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ding

Dr. Jennifer Ding is a hematology & oncology specialist in San Antonio, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Ding performed 44,755 Medicare services across 1,505 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ding received a total of $1,541 from 29 pharmaceutical and/or device companies across 54 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ding is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 22% volume in TX $1,541 industry payments

Medicare Practice Summary

Medicare Utilization ↗
44,755
Medicare services
Top 22% in TX for hematology & oncology
1,505
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,730 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Injectafer) 40,500 $1 $3
Dexamethasone injection (steroid) 696 $0 $0
Blood draw (venipuncture) 446 $8 $15
Complete blood count (CBC) with differential 377 $8 $23
Comprehensive metabolic blood panel 341 $10 $32
Office visit, established patient, complex (40-54 min) 235 $137 $523
Office visit, established patient (30-39 min) 215 $92 $374
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 195 $22 $86
Hospital follow-up visit, high complexity 138 $93 $349
Office visit, established patient (20-29 min) 132 $65 $263
Ferritin level test (iron stores) 129 $13 $41
Administration of chemotherapy into vein, 1 hour or less 128 $101 $377
Iron level test 120 $6 $19
Iron binding capacity test 120 $9 $26
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 86 $48 $185
Injection of additional new drug or substance into vein 83 $12 $58
Administration of additional new drug or substance into vein, 1 hour or less 79 $50 $205
Complete blood count (CBC), automated 69 $6 $19
Lactate dehydrogenase (enzyme) level 66 $6 $18
Drug injection, under skin or into muscle 65 $11 $47
Administration of chemotherapy into vein, each additional hour 63 $22 $90
Prothrombin time test (blood clotting) 57 $4 $13
Injection, diphenhydramine hcl, up to 50 mg 55 $1 $3
New patient office visit (45-59 min) 51 $118 $486
Infusion, normal saline solution , 1000 cc 46 $2 $19
Initial hospital admission, high complexity 43 $136 $583
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg 43 $354 $1,354
Vitamin B-12 level test 42 $14 $45
Immunoglobulin level test 42 $9 $28
Infusion into a vein for hydration, each additional hour 37 $10 $42
Carcinoembryonic antigen (cea) protein level 23 $19 $57
New patient office visit, complex (60-74 min) 22 $156 $639
New patient office visit (30-44 min) 11 $72 $326
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
91.3% high complexity
2.5% medium
6.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,541
Total received (2021-2024)
Avg $385/year across 4 years
Bottom 35% in TX for hematology & oncology
29
Companies
54
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,541 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$703
2023
$451
2022
$206
2021
$181

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$170
Novartis Pharmaceuticals Corporation
$151
Adaptive Biotechnologies Corporation
$148
Daiichi Sankyo Inc.
$129
Amgen Inc.
$125
PharmaEssentia USA Corporation
$76
AstraZeneca Pharmaceuticals LP
$75
Gilead Sciences, Inc.
$66
Janssen Biotech, Inc.
$62
Sandoz Inc.
$56
Kite Pharma, Inc.
$42
GlaxoSmithKline, LLC.
$40
Karyopharm Therapeutics Inc.
$39
CTI BioPharma Corp.
$39
Seagen Inc.
$33
Bayer Healthcare Pharmaceuticals Inc.
$25
Astellas Pharma US Inc
$25
PFIZER INC.
$24
Legend Biotech USA Inc.
$24
AVEO Pharmaceuticals, Inc.
$23
Merck Sharp & Dohme LLC
$22
E.R. Squibb & Sons, L.L.C.
$22
Celgene Corporation
$21
Genmab U.S., Inc.
$19
Mirati Therapeutics, Inc.
$19
EMD Serono, Inc.
$17
Stemline Therapeutics Inc.
$17
Pharmacosmos Therapeutics Inc.
$15
Agios Pharmaceuticals, Inc.
$13
Top 3 companies account for 30.4% of total payments
Associated products mentioned in payments ›
AUGTYRO · BESREMI · ENHERTU · Enhertu · Epkinly · FOTIVDA · IMFINZI · INJECTAFER · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · MEKINIST · MONOFERRIC · OJJAARA · Orserdu · PADCEV · PYRUKYND · Pomalyst · SCEMBLIX · Stivarga · TAGRISSO · TECVAYLI · Vonjo · Vyloy · XPOVIO · ZIEXTENZO · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3 per 100 Medicare services performed
Looking for a hematology & oncology specialist in San Antonio?
Compare hematology & oncology specialists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
56
Per 100K population
2.7
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ding is a mixed practice specialist, with above-average Medicare volume (top 22% in TX), with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ding experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Ding performed 40,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ding receive payments from pharmaceutical companies?
Yes. Dr. Ding received a total of $1,541 from 29 companies across 54 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ding's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Ding's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ding) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →